View in EDS HTML Full Text PDF Full Text

Hypofunction of macrophage chemotaxis contributes to defective efficacy of herceptin in HER2-positive breast cancer patients.

Saved in:
Bibliographic Details
Title: Hypofunction of macrophage chemotaxis contributes to defective efficacy of herceptin in HER2-positive breast cancer patients.
Authors: Song, Yu1 (AUTHOR) songyugzyx@163.com, Geng, Qiao-Chen1 (AUTHOR), An, Wen-Jing1 (AUTHOR), Zhang, Fu-Cheng1 (AUTHOR), Jiang, Ran1 (AUTHOR), Zhao, Rui-Sheng1 (AUTHOR), Deng, Zhi-Jian1 (AUTHOR), Li, Heng2 (AUTHOR) cpuliheng@gmail.com
Source: Molecular & Cellular Oncology. 2024, Vol. 11 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23723556
DOI:10.1080/23723556.2024.2309715